BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 928 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,213,000 | +3.1% | 14,808 | +2.4% | 0.14% | +3.8% |
Q1 2019 | $1,176,000 | +25.1% | 14,465 | +1.3% | 0.13% | +14.7% |
Q4 2018 | $940,000 | -27.6% | 14,274 | -15.2% | 0.12% | -14.1% |
Q3 2018 | $1,299,000 | +4.4% | 16,842 | 0.0% | 0.14% | +0.7% |
Q2 2018 | $1,244,000 | +22.3% | 16,842 | +7.7% | 0.13% | +20.7% |
Q1 2018 | $1,017,000 | +0.6% | 15,642 | 0.0% | 0.11% | +1.8% |
Q4 2017 | $1,011,000 | +34.1% | 15,642 | +30.2% | 0.11% | +29.8% |
Q3 2017 | $754,000 | -31.0% | 12,017 | -33.4% | 0.08% | -29.4% |
Q2 2017 | $1,092,000 | +16.5% | 18,037 | -0.2% | 0.12% | +14.4% |
Q1 2017 | $937,000 | -2.7% | 18,067 | -16.8% | 0.10% | -5.5% |
Q4 2016 | $963,000 | +83.4% | 21,716 | +97.1% | 0.11% | +54.9% |
Q3 2016 | $525,000 | +4.4% | 11,018 | -0.9% | 0.07% | +1.4% |
Q2 2016 | $503,000 | +4.6% | 11,118 | -5.1% | 0.07% | +4.5% |
Q1 2016 | $481,000 | -1.4% | 11,718 | -8.4% | 0.07% | -1.5% |
Q4 2015 | $488,000 | -3.4% | 12,798 | -16.8% | 0.07% | -6.8% |
Q3 2015 | $505,000 | -53.4% | 15,376 | -0.8% | 0.07% | -49.3% |
Q2 2015 | $1,084,000 | +4.9% | 15,501 | +2.8% | 0.14% | +6.7% |
Q1 2015 | $1,033,000 | +1.9% | 15,076 | +9.0% | 0.14% | +2.3% |
Q4 2014 | $1,014,000 | +9.1% | 13,826 | +6.7% | 0.13% | -18.0% |
Q3 2014 | $929,000 | +1.8% | 12,953 | +2.6% | 0.16% | +3.9% |
Q2 2014 | $913,000 | +9.3% | 12,628 | +11.3% | 0.16% | +3.3% |
Q1 2014 | $835,000 | +23.3% | 11,343 | +16.4% | 0.15% | +24.0% |
Q4 2013 | $677,000 | +6.3% | 9,743 | +0.5% | 0.12% | -1.6% |
Q3 2013 | $637,000 | -5.2% | 9,693 | -0.1% | 0.12% | -6.8% |
Q2 2013 | $672,000 | – | 9,701 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |